Kids Born in Lockdown Show Lower Executive Function at Age 4

Published Date: 23 Jul 2026

Kids born in the first COVID lockdown in England show age-appropriate language and motor skills, but executive function remains the key area of concern at age 4 and may need extra support at school.

Read Full News

Latest News

US FDA Widens Investigation Into Cyclosporiasis Cases to Four More States

The U.S. FDA and the CDC are widening their investigation into a cyclosporiasis outbreak linked to shredded iceberg lettuce from central Mexico after identifying ⁠cases in...

Nearly 3,000 Confirmed Infected With Ebola in Congo After Data Review

The number of people confirmed infected with Ebola in the Democratic ⁠Republic of Congo was heading towards 3,000 on Friday after officials reviewed data ⁠in two of the...

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell ⁠lower-cost versions of its experimental once-monthly...

Patients Are Self-Prescribing DoxyPEP. Is This a Problem?

Syphilis cases are rising across Europe. Many are turning to doxycycline to prevent it. Is antimicrobial resistance a concern?

Pfizer's Prostate Cancer Drug Combination Gets US FDA Priority Review

Pfizer said on Wednesday the U.S. Food and Drug Administration had granted priority review to ⁠its application seeking expanded approval for its prostate cancer treatment...

Proton Pump Inhibitors Boost Exacerbations in Bronchiectasis

Consider a deprescribing trial in patients without chronic indications.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Latest News

The U.S. FDA and the CDC are widening their investigation into a cyclosporiasis outbreak linked to shredded iceberg lettuce from central Mexico after identifying ⁠cases in...

The number of people confirmed infected with Ebola in the Democratic ⁠Republic of Congo was heading towards 3,000 on Friday after officials reviewed data ⁠in two of the...

Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell ⁠lower-cost versions of its experimental once-monthly...

Syphilis cases are rising across Europe. Many are turning to doxycycline to prevent it. Is antimicrobial resistance a concern?

Pfizer said on Wednesday the U.S. Food and Drug Administration had granted priority review to ⁠its application seeking expanded approval for its prostate cancer treatment...

Consider a deprescribing trial in patients without chronic indications.

News All Time

Japanese Drugmaker Takeda's Qdenga Becomes First Dengue Vaccine Approved in India

Takeda Pharmaceutical's dengue vaccine Qdenga has been approved by India's drug regulator, making it the first such vaccine to be cleared in the country, the Japanese...

India's Serum Institute Partners With Gates MRI to Make Experimental TB Vaccine

(Corrects to fix typo in the headline)

New Zealand Confirms First H5N1 Bird Flu Case in Native Bird

New Zealand detected on Friday the first infection of a native bird ⁠by the deadly H5N1 bird flu, days after confirming a migratory seabird had tested ⁠positive in the...

Congo Begins Trial Of Gilead's Experimental Antiviral for Ebola Bundibugyo

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

Gen Z Fitness Trend: Are Group Workouts Better?

Community fitness may improve exercise adherence and mental well-being through social support, although evidence shows that it offers few additional physical benefits.

What to Know About the US Outbreak Of Cyclosporiasis

The U.S. Centers for Disease Control and Prevention said on Tuesday it had confirmed 1,645 cases of an intestinal infection from the cyclospora parasite that causes...

Oxford Begins First Human Trial Of Bundibugyo Ebola Vaccine

The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate ⁠efforts to combat an outbreak spreading in the...

Two- vs Three-Drug Combo for HIV Infection: No Clear Winner

Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir plus lamivudine and those on integrase inhibitor-based three-drug regimens.

Nintedanib Shows No Benefit Over Placebo in Post-COVID ILD

Among patients with post-COVID interstitial lung disease, nintedanib does not provide significant benefit over placebo.

Congo Ebola Response Workers Protest Over Pay

Ebola response workers in northeastern Democratic Republic of Congo staged protests outside three treatment centres on Thursday, saying ⁠they had not been paid all they were...

Ebola Outbreak in Congo Still Spreading, WHO Says

The Ebola outbreak in Congo has not yet stabilised and is still expanding as population ⁠movement fuels transmission, a World Health Organization official said on...

Rx Opioids Plus Antidepressants May Lower Cognition in PWH

In people living with HIV, prescription opioids alone are not linked to worse cognition or mood, but when combined with some drugs, notably antidepressants, they are associated with poorer cognition.

WHO Declares Hantavirus Outbreak Linked to Cruise Ship Over

The World Health Organization ⁠on Thursday declared the hantavirus ⁠outbreak linked to a ⁠cruise ship ‌over after the last identified contact of an exposed person completed...

Australia's New South Wales Confirms H5N1 Bird Flu Case, Third State

New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said ⁠a migratory seabird found near a coastal town returned a positive...

Effort to End Respiratory Viruses to Start With Cold & Flu

The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

US Provisional Mortality Rate Falls 4.6% in 2025, Flu Deaths Rise

The U.S. provisional death rate fell 4.6% in 2025, with heart disease, cancer and unintentional injuries remaining the leading causes of mortality, ⁠the Centers for Disease...

Recommended News For You

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

Using MRD Status to Deescalate Multiple Myeloma Therapy

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Scientists develop scans that light up aggressive cancer tumors for better treatment

FDA Approves Sickle Cell Gene Therapy for Young Kids

Prostate Cancer Treatment Associated With Long-Term Complications

Recommended Articles For You

Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology 

An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients 

Clinical Perspectives in Oncology for Better Care 

Strategic Practices in Oncology for Specialists 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mental health risk persists years after cancer diagnosis

2.

Breast cancer prevention: How nurse practitioners and physician assistants can help

3.

For treatment, the majority of cancer patients choose complementary therapies.

4.

Cancer mortality continuing to decline, says report

5.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

1.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

2.

Bone Marrow Microenvironment Biomarkers in Hematologic Health

3.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

4.

HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer

5.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot